Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.
about
Neuroimaging tests for clinical psychiatry: Are we there yet?Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.Alzheimer's Disease Diagnosis: Discrepancy between Clinical, Neuroimaging, and Cerebrospinal Fluid Biomarkers Criteria in an Italian Cohort of Geriatric Outpatients: A Retrospective Cross-sectional Study.Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health.Longitudinal association between brain amyloid beta and gait in the Mayo Clinic Study of Aging.Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer's disease.Tau-negative amnestic dementia masquerading as Alzheimer disease dementia.Corticobasal degeneration: key emerging issues.Defining SNAP by cross-sectional and longitudinal definitions of neurodegeneration.NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.Resistance vs resilience to Alzheimer disease: Clarifying terminology for preclinical studies.Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imaging.Prevalence of preclinical Alzheimer disease: Comparison of current classification systems.Sex Moderates the Impact of Diagnosis and Amyloid PET Positivity on Hippocampal Subfield Volume.The A/T/N biomarker scheme and patterns of brain atrophy assessed in mild cognitive impairment.Mechanisms and modulators of cognitive training gain transfer in cognitively healthy aging: study protocol of the AgeGain study.Molecular Mechanisms of Oligodendrocyte Regeneration in White Matter-Related Diseases.Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia
P2860
Q33842681-62D8E7BC-CCD0-4EC4-99B2-17199532C49AQ41566620-022F8281-6DCA-47ED-87DF-E040B4CFCF7EQ47161166-EF001506-EEF5-447E-A64D-BADC615CC29DQ47562258-AD4C3DD0-D50C-4046-9264-3166CA66B1FAQ47577386-84F5B5DA-C3E6-4810-AD7F-DB7F3ADAF514Q47940819-F003C22E-D4B1-4B9A-A5CF-4D32150BE0BAQ50042853-4E2DE1C2-7567-40D0-BAEC-730FC7620F7CQ50074075-15A22DF0-D9A1-414E-A272-9E7E7F1DA657Q50321758-1DFD83B5-A1E1-4F49-ABAA-C1FB9BB367CEQ52589491-128045C5-CFF1-4FD4-A7E8-B74BC690FEFFQ52625093-6B6C3B16-7CFA-4440-ACE3-40FB4A653A39Q53396720-527B22B2-1D13-4F7C-A500-5BB8C4CD7FE2Q53513203-C6E7009C-EF81-427A-99CF-ACAF30DF1C50Q55417344-C89A0C7F-4BB2-43D8-8449-69747F372D04Q55443417-11315466-AD3F-4DF3-AF8B-56F6D82705ADQ55513025-059E53F6-3585-4824-B988-2A4769323487Q55617506-E8641F3E-F4D7-4972-BF8A-75A55E3D00DEQ58699111-B1A91A88-E19F-4441-A1B4-CBAE45F9F6CC
P2860
Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Age-specific and sex-specific ...... ears: a cross-sectional study.
@en
type
label
Age-specific and sex-specific ...... ears: a cross-sectional study.
@en
prefLabel
Age-specific and sex-specific ...... ears: a cross-sectional study.
@en
P2093
P2860
P50
P1433
P1476
Age-specific and sex-specific ...... ears: a cross-sectional study.
@en
P2093
Heather J Wiste
Jeffrey L Gunter
Mary M Machulda
Matthew L Senjem
Michelle M Mielke
Prashanthi Vemuri
Rosebud O Roberts
Stephen D Weigand
Terry M Therneau
P2860
P304
P356
10.1016/S1474-4422(17)30077-7
P577
2017-04-26T00:00:00Z